Skip to main content

Table 1 The usage of vancomycin in the pre-intervention and intervention periods

From: Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasi-experimental study in a region of high MRSA prevalence

  Pre-intervention period Intervention period P value
Total amount of vancomycin prescribed (DDDs/1000 patient-days) 37.6 32.1 < 0.001
Amount of empirical vancomycin (DDDs/1000 patient-days) 23.9 19.9 0.005
Amount of inappropriate continued empirical vancomycin (DDDs/1000 patient-days) 8.0 5.8 0.009
  1. Abbreviations: DDD defined daily dose